NCT00476307View on ClinicalTrials.gov

Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

June 30, 2007

Study Completion Date

July 31, 2007

Conditions

Influenza

Interventions

BIOLOGICAL

Fluarix™/Influsplit SSW® 2007/2008

Trial Locations (3)

01099

GSK Investigational Site, Dresden

01307

GSK Investigational Site, Dresden

01705

GSK Investigational Site, Freital

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY